Molecular mechanism (s) of regulation (s) of c-MET/HGF signaling in head and neck cancer
Head and neck cancer is the sixth most common cancer across the globe. This is generally
associated with tobacco and alcohol consumption. Cancer in the pharynx majorly arises …
associated with tobacco and alcohol consumption. Cancer in the pharynx majorly arises …
Targeting cellular metabolism in head and neck cancer precision medicine era: A promising strategy to overcome therapy resistance
X Lin, W Zhou, Z Liu, W Cao, C Lin - Oral Diseases, 2023 - Wiley Online Library
Head and neck squamous cell carcinoma (HNSCC) is among the most prevalent cancer
worldwide, with the most severe impact on quality of life of patients. Despite the …
worldwide, with the most severe impact on quality of life of patients. Despite the …
Tanshinone IIA inhibits oral squamous cell carcinoma via reducing Akt-c-Myc signaling-mediated aerobic glycolysis
Aerobic glycolysis is one of the hallmarks of human cancer cells. Overexpression of
hexokinase 2 (HK2) plays a crucial role in the maintaining of unlimited tumor cell growth. In …
hexokinase 2 (HK2) plays a crucial role in the maintaining of unlimited tumor cell growth. In …
The glutaminase inhibitor telaglenastat enhances the antitumor activity of signal transduction inhibitors everolimus and cabozantinib in models of renal cell carcinoma
E Emberley, A Pan, J Chen, R Dang, M Gross… - PLoS …, 2021 - journals.plos.org
Dysregulated metabolism is a hallmark of cancer that manifests through alterations in
bioenergetic and biosynthetic pathways to enable tumor cell proliferation and survival …
bioenergetic and biosynthetic pathways to enable tumor cell proliferation and survival …
Cancer-associated fibroblasts: Mediators of head and neck tumor microenvironment remodeling
M Raudenska, J Balvan, K Hanelova… - … et Biophysica Acta (BBA …, 2023 - Elsevier
Cancer-associated fibroblasts (CAFs) are involved in critical aspects of head and neck
squamous cell carcinoma (HNSCC) pathogenesis, such as the formation of a tumor …
squamous cell carcinoma (HNSCC) pathogenesis, such as the formation of a tumor …
[HTML][HTML] Unveiling the Role of HGF/c-Met Signaling in Non-Small Cell Lung Cancer Tumor Microenvironment
S Yao, X Liu, Y Feng, Y Li, X **ao, Y Han… - International Journal of …, 2024 - mdpi.com
Non-small cell lung cancer (NSCLC) is characterized by several molecular alterations that
contribute to its development and progression. These alterations include the epidermal …
contribute to its development and progression. These alterations include the epidermal …
c-Met signaling as a therapeutic target in head and neck cancer
SM Centuori, JE Bauman - The Cancer Journal, 2022 - journals.lww.com
Despite a dearth of activating driver mutations in head and neck squamous cell carcinoma
(HNSCC), aberrant activation of the oncogenes, epidermal growth factor receptor (EGFR) …
(HNSCC), aberrant activation of the oncogenes, epidermal growth factor receptor (EGFR) …
PKM2 modulation in head and neck squamous cell carcinoma
V Boschert, J Teusch, UDA Müller-Richter… - International Journal of …, 2022 - mdpi.com
The enzyme pyruvate kinase M2 (PKM2) plays a major role in the switch of tumor cells from
oxidative phosphorylation to aerobic glycolysis, one of the hallmarks of cancer. Different …
oxidative phosphorylation to aerobic glycolysis, one of the hallmarks of cancer. Different …
Protein phosphatase 2A as a therapeutic target in small cell lung cancer
T Mirzapoiazova, G **ao, B Mambetsariev… - Molecular cancer …, 2021 - AACR
Abstract Protein phosphatase 2A (PP2A), a serine/threonine phosphatase involved in the
regulation of apoptosis, proliferation, and DNA-damage response, is overexpressed in many …
regulation of apoptosis, proliferation, and DNA-damage response, is overexpressed in many …
Molecular phenotypes of circulating tumor cells and efficacy of nivolumab treatment in patients with head and neck squamous cell carcinoma
H Tada, H Takahashi, R Kawabata-Iwakawa… - Scientific Reports, 2020 - nature.com
The emergence of immune checkpoint inhibitors (ICIs) has revolutionized the treatment of
recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC). Biomarkers …
recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC). Biomarkers …